Back
Altisource Portfolio Solutions SA Vs. Cidara Therapeutics Industry Stock Comparison
Buy
55
ASPS
Altisource Portfolio Solutions SA
Last Price:
$13.54
Seasonality Move:
4.63%
Buy
83
CDTX
Cidara Therapeutics
Last Price:
$50.88
Seasonality Move:
0.55%
Buy
55
Altisource Portfolio Solutions SA (ASPS)
is a Buy
Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?
-
The current Altisource Portfolio Solutions SA [ASPS] share price is $11.67. The Score for ASPS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ASPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.45. The Score for CDTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ASPS Stock Price Chart
What is Altisource Portfolio Solutions SA's stock price today?
-
The Altisource Portfolio Solutions SA share price today is $11.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASPS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASPS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.79 | Buy |
Relative Strength Index (14 RSI): | 70.88 | Buy |
Chaikin Money Flow: | 68026 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.18 - 10.32) | Buy |
Bollinger Bands (100): | (5.66 - 8.5) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.06 | Buy |
Relative Strength Index (14 RSI): | 78.48 | Buy |
Chaikin Money Flow: | 1068479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.14 - 46.86) | Buy |
Bollinger Bands (100): | (16.26 - 33.4) | Buy |
ASPS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.6 | Buy |
20-day SMA: | 9.38 | Buy |
50-day SMA: | 7.87 | Buy |
200-day SMA: | 7.15 | Buy |
8-day EMA: | 10.05 | Buy |
20-day EMA: | 9.26 | Buy |
50-day EMA: | 8.19 | Buy |
200-day EMA: | 8.64 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.83 | Buy |
20-day SMA: | 37.16 | Buy |
50-day SMA: | 28.26 | Buy |
200-day SMA: | 21.03 | Buy |
8-day EMA: | 47.24 | Buy |
20-day EMA: | 40.11 | Buy |
50-day EMA: | 31.72 | Buy |
200-day EMA: | 22.83 | Buy |
Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Altisource Portfolio Solutions SA Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |